Pancreas Transplant for Diabetes: Benefits, Risks & Candidacy

Pancreas transplantation restores endogenous insulin production, primarily for type 1 diabetes with severe complications.

Indications

  • Type 1 DM + end-stage renal disease (simultaneous pancreas-kidney / SPK — most common).
  • Type 1 DM + life-threatening hypoglycemia unawareness despite optimal medical therapy (pancreas after kidney / PAK, or pancreas alone / PTA).

Benefits

  • Insulin independence (~80% at 1 yr, ~60% at 5 yr).
  • Improved glycemic control → slows microvascular complications (retinopathy, neuropathy, nephropathy in native kidney).
  • Quality of life: Freedom from injections, monitoring, hypoglycemia fear.
  • Survival advantage vs. waitlist (especially SPK).

Risks

  • Surgical: Thrombosis (graft loss), pancreatitis, leak, infection, bleeding.
  • Immunosuppression (lifelong): Infection, malignancy, nephrotoxicity (tacrolimus), metabolic syndrome.
  • Rejection: Acute (treated), chronic (graft loss).

Candidate Selection

  • Age typically <50–55 (varies by center).
  • BMI <30–32; no active infection/malignancy; cardiac/pulmonary clearance.
  • Commitment to lifelong immunosuppression & follow-up.

Multidisciplinary evaluation (transplant surgeon, nephrologist, endocrinologist, psychologist, social worker) determines eligibility.

Diabetes - Related Articles